Cartesian Therapeutics, Inc. (RNAC)
6.52
+0.11
(+1.72%)
USD |
NASDAQ |
Feb 13, 15:32
Cartesian Therapeutics Profit Margin (Quarterly) : -7.94K% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 25.76% |
| Alnylam Pharmaceuticals, Inc. | 20.10% |
| Savara, Inc. | -- |
| BioMarin Pharmaceutical, Inc. | -3.91% |
| Imunon, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -15.68% |
| Gross Profit Margin (Quarterly) | -97.65% |
| Operating Margin (Quarterly) | -4.66K% |
| Return on Net Operating Assets | -27.33% |